You are here: Industry Insights > COVID-19

News List

COVID-19 heart changes raise death risk; virus may be lead killer of young adults during surges expresspharma
October 27, 2020
A new study may help identify which COVID-19 patients with signs of heart injury are at higher risk for death. Doctors looked at 305 hospitalised patients with elevated levels of troponin, a protein released when the heart has been injured.
Canada's Prime Minister, Justin Trudeau, Announced Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19 prnewswire
October 26, 2020
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and ...
Aspirin could protect patients from severe COVID-19 complications europeanpharmaceuticalreview
October 26, 2020
A study has shown that aspirin use was associated with a 47 percent decrease in the risk of dying in the hospital from COVID-19.
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs pharmatimes
October 26, 2020
German pharma company Merck KGaA has partnered with non-profit scientific research organisation IAVI and Serum Institute of India to develop monoclonal antibodies (mAbs) for COVID-19.
IncellDx to Study Maraviroc in COVID-19 Phase 2 Clinical Trial americanpharmaceuticalreview
October 26, 2020
IncellDx will collaborate on the SARS-CoV2 Clinical Trial NCT04435522 involving Pfizer's FDA-approved CCR5 antagonist Maraviroc.
Peru refuses Covid-19 vaccine purchase deal with AstraZeneca pharmaceutical-technology
October 26, 2020
The Peruvian government has refused to sign an agreement with AstraZeneca to purchase coronavirus vaccine as the latter failed to provide sufficient data from its studies.
LaunchWorks CDMO Approved to Provide Viral Transport Media contractpharma
October 26, 2020
?LaunchWorks CDMO, a contract development and manufacturing company serving the life science market, has been approved to manufacture and distribute Viral Transport Media (VTM), in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
Gilead gets USFDA approval for Veklury (remdesivir) to treat COVID-19 expresspharma
October 26, 2020
Gilead Sciences announced that the US Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalisation.
USFDA approves IND application from Reven Pharma for Rejuveinix to treat COVID-19 expresspharma
October 26, 2020
RJX is an IV formulation being developed for treatment of inflammatory disorders, including COVID-19 patients with viral sepsis, multi-system inflammation, cytokine release syndrome, shock, ARDS and multi-organ failure.
PNB Vesper to commence phase II clinical trial of COVID-19 drug in BJ Medical College, Pune expresspharma
October 26, 2020
The company has already patented the molecule and secured intellectual property rights in the US, Europe and rest of the world.